Ultrashort Echo Time (UTE) MRI for Applicator Reconstruction in Gynaecologic Cancer Brachytherapy
Key facts
- Who runs it
- Mahidol University
- Where
- Thailand1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 50 people, planned
- Starts
- Dec 2026
- Expected to end
- Dec 2029
- Type of study
- Interventional
- Treatments tested
- Ultrashort Echo Time (UTE) MRI
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Gynaecologic malignancy (cervix/endometrium/vagina) requiring BT with intracavitary or hybrid IC/IS applicator
- Locally advanced cervical, endometrial, or vaginal cancer undergoing MRI-guided BT
- Age ≥ 18 years
- ECOG 0-2
- Written informed consent
Who cannot take part
- MRI contraindication (incompatible implant, severe claustrophobia)
- non-MRI-compatible applicator required
- inability to tolerate ~8 mins additional scan time
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Cervical cancer or endometrium cancer or vagina cancer
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical study is to learn whether an ultrashort echo time (UTE) MRI scan can show the position of brachytherapy applicators and needles more accurately than standard MRI scans in adults with gynaecologic cancer (cervical, endometrial, or vaginal cancer) who are receiving MRI-guided internal radiotherapy (brachytherapy).
Read full original descriptionShow less
The main questions it aims to answer are:
* Does UTE MRI locate the applicator and needle tips more accurately than standard T2-weighted (T2W) and proton-density-weighted (PDW) MRI, when compared with CT? * Does UTE MRI show a clearer contrast between the applicator and the surrounding tissue?
Researchers will compare applicator positions reconstructed from UTE, T2W, and PDW MRI with CT taken on the same day as the reference standard. They will also check whether differences in applicator reconstruction change the planned radiation dose, and whether image features (radiomics) from UTE MRI before treatment and before brachytherapy help predict cancer recurrence.
Participants will:
* Receive their usual standard brachytherapy treatment, which is not changed by this study * Have one additional MRI sequence (UTE, about 8 minutes) added to their standard MRI and CT scans at each brachytherapy planning session, with the applicator in place * Have an additional UTE sequence added to their routine MRI before treatment and before brachytherapy * Be followed during routine clinical visits for disease outcomes
The group in the trial
- UTE MRITreatment being tested
Gynaecologic malignancy (cervix/endometrium/vagina) requiring BT with intracavitary or hybrid IC/IS applicator. At every planning/fraction session: T2W, PDW, 3D UTE (1.5 mm isotropic) and same day CT (reference), all with applicator in situ on a Philips 1.5T system. An additional UTE sequence will be acquired alongside the standard T2W and DWI sequences at pre-treatment and pre-brachytherapy time points.
Treatment: Ultrashort Echo Time (UTE) MRI
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07940361, who can take part
- Record updated
- 16 November 2026